Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View expanded data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View expanded data table
# of AnimalsPhenotypeStrainSexValueUnitsConditionsRecord ID
10percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kinimale30%myelin oligodendrocyte glycoprotein (20 ug) 68718myelin oligodendrocyte glycoprotein (20 ug)
3post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat2-D10Rat29)/Kinimale14.7dmyelin oligodendrocyte glycoprotein (20 ug) 68719myelin oligodendrocyte glycoprotein (20 ug)
3percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kinimale0%myelin oligodendrocyte glycoprotein (20 ug) 68721myelin oligodendrocyte glycoprotein (20 ug)
10percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kinimale0%myelin oligodendrocyte glycoprotein (20 ug) 68722myelin oligodendrocyte glycoprotein (20 ug)
8percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kinimale0%myelin oligodendrocyte glycoprotein (20 ug) 68724myelin oligodendrocyte glycoprotein (20 ug)
7percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kinimale14%myelin oligodendrocyte glycoprotein (20 ug) 68726myelin oligodendrocyte glycoprotein (20 ug)
1post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat2-D10Rat29)/Kinimale23dmyelin oligodendrocyte glycoprotein (20 ug) 68727myelin oligodendrocyte glycoprotein (20 ug)
1percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kinimale0%myelin oligodendrocyte glycoprotein (20 ug) 68729myelin oligodendrocyte glycoprotein (20 ug)
1post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat2-D10Rat29)/Kininot specified3dmyelin oligodendrocyte glycoprotein (200 ul) 68730myelin oligodendrocyte glycoprotein (200 ul)
6post-insult time to onset of experimental autoimmune encephalomyelitisDA.ACI-(D10Rat2-D10Rat29)/Kininot specified13.3dmyelin oligodendrocyte glycoprotein (200 ul) 68731myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified37.5%myelin oligodendrocyte glycoprotein (200 ul) 68732myelin oligodendrocyte glycoprotein (200 ul)
7percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified0%myelin oligodendrocyte glycoprotein (200 ul) 68733myelin oligodendrocyte glycoprotein (200 ul)
7percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified14.3%myelin oligodendrocyte glycoprotein (200 ul) 68734myelin oligodendrocyte glycoprotein (200 ul)
8percentage of study population developing experimental autoimmune encephalomyelitis during a period of timeDA.ACI-(D10Rat2-D10Rat29)/Kininot specified75%myelin oligodendrocyte glycoprotein (200 ul) 68735myelin oligodendrocyte glycoprotein (200 ul)